Sol de Janeiro

Q1 2025

You Were First. What Are You Next?

Issue

Q1 2025

Published

recuHaGw2JuE3x4aS

Brand Worth Watching

Sol de Janeiro

The Blind Spot

Every investor who priced a founder-credentialed prestige brand in the last five years used a model that treated editorial authority as an acquirable asset. The Pat McGrath Labs bankruptcy is the first proof that model is wrong.

Prestige beauty was flat in Q1 2025. Mass grew 3 percent, outpacing prestige for the first time in several years.

In this issue

The Quarter in Brand Authority

The Brand Worth Watching — Sol de Janeiro

The Vocabulary Shift

Category Signals

The Blind Spot

The Question

The Quarter in Brand Authority

The headline reads as a category reversal. It is not. It is the category correcting for a post-pandemic run that was never going to sustain its pace, and a January consumer pullback that improved significantly through February and March. By March, every prestige category was growing again. The Q1 flatness is a single quarter of normalization, not a structural shift.

What is structural is what Q1 is confirming about prestige skincare. Dollar sales declined 3 percent while units sold grew 1 percent. The consumer is buying prestige skincare but paying less for it. She is finding prestige skincare at lower price points within the prestige channel. The masstige brands sitting between mass and prestige are capturing her. The brands that held share are the ones where the price is justified by something she cannot find at a lower price. The brands softening are the ones where the price is justified primarily by positioning.

Color cosmetics posted its first real softness in Q1 2025: prestige makeup declined 1 percent in dollars. The lip segment, which had carried color for two years on hybrid formats, went flat. This is the moment the skinification thesis gets tested. Brands leading with specific actives -- branded peptide complexes, documented barrier support, a named dermatologist in their development story -- are outperforming brands leading with color range. The category's problem in Q1 is not that makeup stopped mattering. It is that the consumer is now applying a skincare standard to her makeup purchase, and most makeup brands have not built the proof architecture to meet it.

Sol de Janeiro fell eight spots in Q1 brand indexes. Every competitor that launched a body mist since 2021 did so because Sol de Janeiro proved the consumer would pay prestige prices for it. That success invited its own replication, and every replication dilutes the brand's claim to the territory it created. The question is whether the brand's innovation response builds a new authority position or simply defends the old one.

Olaplex reported Q1 2025 net sales of approximately $97 million, down 1.9 percent year over year. The professional channel declined 10.9 percent. The specialty retail channel grew 12 percent. A brand losing its professional authority base while rebuilding a consumer authority base through retail. The emotional connection strategy is a bridge, not a solution. What restores Olaplex's authority is making the science impossible to ignore again.

The Brand Worth Watching

Sol de Janeiro launched in 2015 with a body cream. It created the prestige body mist category in 2017. By 2024, it was the number one brand at Sephora -- a position no body care brand had ever occupied -- with fragrance mists generating $573 million in US sales. The brand achieved this through scent: a specific, identifiable olfactory signature built around Brazilian gourmand notes that no competitor had occupied before.

That is a remarkable asset. It is also the specific kind of asset that is difficult to sustain once the category saturates around it.

In Q1 2025, the saturation is visible. Phlur, Kylie Cosmetics, Rare Beauty, and others launched body mists. Sol de Janeiro's Ulta expansion in 2024 weakened its Sephora exclusivity. Search interest is declining. Cosmetify's Q1 index dropped the brand eight spots.

This is not a surprise. In Q2 2024, this Brief flagged the distribution expansion as a trade worth watching: significant revenue in exchange for something harder to quantify. What Sol de Janeiro is experiencing in Q1 2025 is the second half of that trade arriving.

The brand's founder, Heela Yang, said it plainly: we need to get the word defend out of our vocabulary. Once you start defending, you just spend your life defending. That is the right frame.

The interesting thing about Sol de Janeiro's current positioning is that it still owns something no competitor has replicated: the specific Brazilian identity that made the brand culturally coherent. The beach, the pistachio-and-vanilla signature, the body confidence ethos -- none of that has been borrowed successfully by any competitor that entered the body mist category. They borrowed the format. They did not borrow the origin.

If Sol de Janeiro's next chapter is built on that foundation, it can outlast the body mist saturation. If the next chapter is more formats organized around what is trending in the category, it will spend the next several years competing for its own shelf position.

The Vocabulary Shift

The term entering this quarter: biotech. It is appearing in beauty and wellness brand copy for the first time as a primary positioning word rather than a descriptor for a single ingredient. Brands using precision fermentation, lab-grown actives, and synthetic biology are beginning to use biotech as the organizing concept for their positioning. The term carries scientific authority that clinical has already begun to lose through overclaiming. Biotech is at the entry stage.

Exiting: clean beauty. The phrase has not disappeared from brand copy, but it has lost its authority signal entirely. In 2018 clean beauty communicated a specific stance: no parabens, no phthalates, no sulfates, a commitment to formulation transparency. In Q1 2025 clean beauty is on the packaging of every brand at every price point. A positioning that is universal is not a positioning. Clean beauty has become the new natural -- present everywhere, differentiating nowhere.

Category Signals

Skincare, fragrance, color cosmetics, hair, and wellness signals tracked across observation, validation, and forecast.

Skincare — Prestige Softens, Proof Holds
Prestige skincare declined 3 percent in Q1 2025 in dollars while units grew 1 percent. The consumer is still buying prestige skincare; she is paying less per unit. Masstige skincare grew double digits while prestige declined. Augustinus Bader, growing through the decline, has TFC8. The Ordinary, growing at the masstige price point, has documented ingredient concentrations and transparent pricing. Both ends of the quality proof spectrum are holding. The middle -- brands with prestige pricing and no specific authority claim -- is softening. Forecast: prestige skincare will not recover until mid-tier brands clarify their proof architecture.

Fragrance — Normalization, Not Retreat
Prestige fragrance grew 4 percent in Q1 2025, a deceleration from 14 percent through September 2024. Fragrance remains the top-performing prestige category in Q1, ahead of makeup, skincare, and hair. Mini and travel sizes grew 45 percent in units within prestige outlets. Forecast: fragrance will remain the most reliable prestige growth driver through 2025, but growth will be more specifically earned. Brands with a clear olfactory identity will grow. Brands that rode the body mist wave without building a fragrance point of view will experience the pullback normalization brings.

Color Cosmetics — Functional Makeup or Irrelevance
Prestige makeup declined 1 percent in Q1 2025, the first meaningful softness. Face and eye were the most challenged. Lip went flat after two years of outperformance. Validation: clinical brands' makeup grew 40 percent in 2024 by media impact value, the steepest growth of any beauty segment. Forecast: 2025 is the bifurcation year for prestige color. Brands with documented skincare actives in their makeup formulas will hold. Brands leading with trend and shade range alone will post their first down quarters.

Hair — Scalp Microbiome as Next Frontier
If 2024 was the year the scalp became treated as a skin surface, Q1 2025 is the beginning of the next phase: the scalp microbiome as the primary framework for scalp health. Fermented actives from rice and kombucha are appearing in formulations from Prose, The Rootist, and Cecred. Validation: BeautyMatter's January 2025 hair trends forecast named 2025 explicitly as the year of the scalp microbiome. Forecast: brands that build this premise with documented microbiome science will hold authority. Brands adding microbiome to existing scalp products without the science will participate in the term's eventual commodification.

Wellness — Longevity Becomes a Purchase Category
The consumer is not just reading about longevity skincare. She is buying it. OneSkin, 111SKIN, and timeline-integrated skincare brands are generating documented sales growth on the longevity premise. Search interest in longevity molecules like NMN and NAD+ tripled in 2024. Forecast: longevity skincare will be the dominant growth narrative in prestige wellness through 2026 and 2027. The brands that can demonstrate biological age improvement -- measured outcomes rather than aspirational language -- will own the most defensible positions.

The Blind Spot

The category has spent the past 18 months analyzing Drunk Elephant's decline through the lens of a brand that lost its core consumer to a younger one. That is accurate but incomplete.

The narrative this quarter is that mass outperformed prestige for the first time in years, and the category is reading this as evidence of a structural consumer shift toward value. The number requires closer reading. Mass beauty sales grew 3 percent in dollars, but unit sales in mass were down 1 percent. Mass outperformed on dollars because of price increases, not because more consumers were buying. Prestige was flat in dollars with units roughly flat. Neither channel is growing in volume terms. The category is having a conversation about which channel is winning when the data is actually describing a consumer who is not expanding her purchase behavior in either direction. She is buying what she intended to buy at the prices she is being charged. The real story is not prestige versus mass. It is that total beauty volume is stagnant, and the brands that will grow through stagnation are not the ones with the right channel strategy but the ones with the strongest reason to be chosen at all.

The Question

Sol de Janeiro created the prestige body mist category. Every brand that followed did so because Sol de Janeiro showed the market what was possible.

What did your brand create that the category has since adopted as standard? And if you can no longer claim it as yours, what is the thing only you could create next?

First-mover advantage is not permanent. The brands that sustain authority do not defend their original position. They discover the next one before the category realizes it exists.